HIGHLIGHTS
- who: Katharina A. Sterenczak et al. from the Department of Ophthalmology, Rostock University Medical Center, Rostock, Germany have published the paper: The Antibiotic Kitasamycinu2014A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?, in the Journal: Pharmaceutics 2023, 329 of 14/05/2022
- what: Within this study a possible antifibrotic potential of kitasamycin (KM) in a transforming growth factor (TGF)-u03b21-mediated fibroblast model was evaluated in vitro. Culture Model Analogous to , the immunofluorescence experiments in this study focused on the fibrosis markers fibronectin and u03b1-SMA, whereas the Western blot analyses included . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.